Integrated Evaluation of Age-Related Changes in Structural and Functional Vascular Parameters Used to Assess Arterial Aging, Subclinical Atherosclerosis, and Cardiovascular Risk in Uruguayan Adults: CUiiDARTE Project
Table 1
Anthropometric and biochemical measurements of the seven different age groups.
≤20 years
21–30 years
31–40 years
41–50 years
51–60 years
61–70 years
71–80 years
MV ± SD
MV ± SD
MV ± SD
MV ± SD
MV ± SD
MV ± SD
MV ± SD
74
79
43
50
59
50
33
Gender (male, %)
44
49
38
44
51
39
46
Age [years]
19.1 ± 0.2
24.8 ± 1.1
35.0 ± 2.7
45.7 ± 3.4
56.4 ± 4.0
64.3 ± 4.9
74.0 ± 3.3
Body height (cm)
167.1 ± 8.3
166.3 ± 8.2
163.1 ± 6.5
166.4 ± 10.5
159.4 ± 4.3
166.0 ± 15.1
158.0 ± 8.1
Body weight (Kg)
59.4 ± 7.6
59.9 ± 8.4
56.1 ± 6.8
63.3 ± 10.5
56.6 ± 6.5
65.7 ± 10.0
62.0 ± 8.1
Body mass index (Kg/m2)
21.3 ± 1.8
21.7 ± 4.1
21.1 ± 2.1
22.8 ± 2.2
22.3 ± 2.4
23.8 ± 0.8
24.8 ± 1.0
Total cholesterol (mg/dL)
184.8 ± 34.1
175.2 ± 24.9
190.2 ± 21.6
184.9 ± 18.3
219.4 ± 8.9
190.5 ± 21.8
183.0 ± 23.1
HDL-cholesterol (mg/dL)
63.5 ± 7.9
64.6 ± 13.8
68.0 ± 27.0
67.5 ± 6.4
73.0 ± 19.5
66.0 ± 10.2
64.0 ± 9.2
LDL-cholesterol (mg/dL)
102.0 ± 21.0
92.0 ± 19.2
111.7 ± 29.6
100.5 ± 6.4
128.7 ± 12.4
92.0 ± 12.2
90.0 ± 13.2
Triglycerides (mg/dL)
96.5 ± 47.8
85.4 ± 27.4
58.3 ± 20.5
57.5 ± 2.1
60.3 ± 20.8
64.0 ± 18.1
80.0 ± 5.1
Total cholesterol/HDL cholesterol
2.9 ± 0.3
2.8 ± 0.6
3.0 ± 1.1
2.7 ± 0.1
3.1 ± 0.9
2.9 ± 0.2
2.8 ± 0.1
Non-HDL cholesterol
121.3 ± 27.5
110.5 ± 22.8
123.7 ± 32.3
112.0 ± 7.1
140.7 ± 16.8
124 ± 17.3
119.3 ± 19.3
Glycaemia (mg/dL)
79.3 ± 2.2
84.1 ± 5.9
69.2 ± 16.5
74.0 ± 19.1
76.0 ± 15.8
72.5 ± 6.4
82.0 ± 12.1
Family history of premature CVD [%]
3
3
4
3
3
5
5
Mean (MV) ± standard deviation (SD). HDL and LDL: high and low density lipoprotein cholesterol, respectively. : number of subjects. CVD: cardiovascular disease.
